145 related articles for article (PubMed ID: 25246260)
1. [Modified bortezomib-based combination therapy for multiple myeloma].
Wei D; Zhao C; Zhao M; Wei J; Gao Y; Cai Q; Wang C
Zhonghua Xue Ye Xue Za Zhi; 2014 Sep; 35(9):854-6. PubMed ID: 25246260
[No Abstract] [Full Text] [Related]
2. Incorporating monoclonal antibodies into the therapy of multiple myeloma.
Bladé J; de Larrea CF; Rosiñol L
J Clin Oncol; 2012 Jun; 30(16):1904-6. PubMed ID: 22291081
[No Abstract] [Full Text] [Related]
3. [Analysis of Bortezomib-containing combinations in newly-diagnosed multiple myeloma patients: a comparative study].
Xu L; Qiu H; Hu X; Lyu S; Song X; Chen L; Zhang W; Gao L; Xu X; Wang J; Yang J
Zhonghua Xue Ye Xue Za Zhi; 2014 May; 35(5):448-50. PubMed ID: 24857218
[No Abstract] [Full Text] [Related]
4. Bortezomib plus melphalan and prednisone for multiple myeloma.
Islam A; Ambrus JL
N Engl J Med; 2008 Dec; 359(24):2613; author reply 2613-4. PubMed ID: 19073984
[No Abstract] [Full Text] [Related]
5. Bortezomib plus melphalan and prednisone for multiple myeloma.
Avvisati G
N Engl J Med; 2008 Dec; 359(24):2613; author reply 2613-4. PubMed ID: 19090032
[No Abstract] [Full Text] [Related]
6. [About treatment of multiple myelomas. A report at the 10th International Workshop in Sydney].
Recenti Prog Med; 2005; 96(7-8):405-9. PubMed ID: 16209124
[No Abstract] [Full Text] [Related]
7. Scleromyxedema and dermato–neuro syndrome in a patient with multiple myeloma effectively treated with dexamethasone and bortezomib.
Fett NM; Toporcer MB; Dalmau J; Shinohara MM; Vogl DT
Am J Hematol; 2011 Oct; 86(10):893-6. PubMed ID: 22026006
[No Abstract] [Full Text] [Related]
8. What is the correct philosophy for the treatment of multiple myeloma?
Gertz MA
Leuk Lymphoma; 2007 Dec; 48(12):2298-9. PubMed ID: 18066999
[No Abstract] [Full Text] [Related]
9. Bortezomib plus melphalan and prednisone for multiple myeloma.
Tsubokura M; Kami M; Komatsu T
N Engl J Med; 2008 Dec; 359(24):2613; author reply 2613-4. PubMed ID: 19090031
[No Abstract] [Full Text] [Related]
10. Multiple myeloma with testicular involvement.
Hwang YY; Chim CS; Shek TW
J Clin Oncol; 2008 Mar; 26(9):1558-9. PubMed ID: 18349409
[No Abstract] [Full Text] [Related]
11. Relapse/Refractory myeloma patient: potential treatment guidelines.
San Miguel JF
J Clin Oncol; 2009 Dec; 27(34):5676-7. PubMed ID: 19786652
[No Abstract] [Full Text] [Related]
12. Bortezomib, cyclophosphamide, and dexamethasone: highly effective for rapid reversal of myeloma-associated hyperammonemic encephalopathy.
Howman R; Thakerer A; Pitman M; Ding N; Thompson PA; Khot A; Harrison SJ
Leuk Lymphoma; 2010 Dec; 51(12):2299-302. PubMed ID: 20929329
[No Abstract] [Full Text] [Related]
13. Immortal time bias and reverse causality in retrospective analysis: Comment on "effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib-melphalan-prednisone in the phase III VISTA study".
Hsieh PY; Liu CJ; Teng CJ
Am J Hematol; 2015 Aug; 90(8):E146. PubMed ID: 25916914
[No Abstract] [Full Text] [Related]
14. Bendamustine: the remedy that came in from the cold.
Lentzsch S
Blood; 2014 Feb; 123(7):948-50. PubMed ID: 24526773
[No Abstract] [Full Text] [Related]
15. Hematology: Bortezomib and dexamethasone induction for multiple myeloma.
Laubach J; Richardson P
Nat Rev Clin Oncol; 2011 Jan; 8(1):8-10. PubMed ID: 21179054
[No Abstract] [Full Text] [Related]
16. The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens.
Benevolo G; Larocca A; Gentile M; Pregno P; Gay F; Botto B; Frairia C; Evangelista A; Morabito F; Boccadoro M; Vitolo U; Palumbo A
Cancer; 2011 May; 117(9):1884-90. PubMed ID: 21509765
[TBL] [Abstract][Full Text] [Related]
17. RAS mutation status and bortezomib therapy for relapsed multiple myeloma.
Smith D; Armenteros E; Percy L; Kumar M; Lach A; Herledan G; Stubbs M; Downward J; Yong K
Br J Haematol; 2015 Jun; 169(6):905-8. PubMed ID: 25580780
[No Abstract] [Full Text] [Related]
18. [The clinical study on treatment with bortezomib for multiple myeloma].
Chen C; Zhao CL; Hou M
Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):265-7. PubMed ID: 21569711
[No Abstract] [Full Text] [Related]
19. [Treatment of multiple myeloma with lenalidomide and bortezomib combination therapy].
Takeda Y; Sakaida E; Nakaseko C
Nihon Rinsho; 2015 Jan; 73(1):130-6. PubMed ID: 25626318
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of bortezomib in combination with dexamethasone for the treatment of multiple myeloma].
Wang LX; Lu H; Shen WY; Qian SX; Qiu HX; Wu HX; Zhang JF; Wu YJ; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):943-5. PubMed ID: 18718096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
